Out-licensing
- Out-licensing
- View
Diclofenac potassium immediate release tablets 25 and 50 mg
Full description
Our formulation in tablets has the main following marketing claims: - immediate release profile (Cmax in 22 min. compared to 50 min. of Cataflam) - regularity of absorption (reduced standard deviation); - Cost competitive manufacturing process (dry mixing for direct compression) The product has been already licensed out exclusively to Spirig Pharma AG for Switzerland and non exclusively for Italy to a local company as well as in New Zealand to the company Douglas Pharmaceuticals, inc..
The product is already approved in Switzerland and New Zealand where it has been already launched under the Brand Name of Inflamac Rapid and Oraflam respectively. An EU Standard CTD Dossier is available for submission and registration in Europe and elsewhere.
Development status
Patent information
The patent has been granted in the following countries: Europe, South Africa, New Zealand Australia and Poland. The Patent is still pending in the following countries: Argentina, Canada, Switzerland, Taiwan, USA.
Type of business relationship sought
Licensing agreements in available countries.
Related reports
Licensing contact
Company details
APR is a private, independent, integrated Healhcare Company focused on Delivering, Funding and Supporting Innovation in Healthcare.
View profileRelated technologies
- APR Fastest for Migraine
- Diclofenac Sodium 25 mg. immediate release tablets
- Technology for Immediate release of oral forms based on Diclofenac
- Product enhancement of small and large molecules in a range of dosage forms
- Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Related categories
- Industry sector
- Pharmaceutical / Prescription
- Drug delivery / Oral solid / Tablet
- Therapeutic target
- Musculoskeletal / Skeletal / Arthritis (non-specific)
- Musculoskeletal / Back pain
- Musculoskeletal / Muscular / Inflammation
- Central Nervous System / Pain / Pain management general
- Central Nervous System / Pain / Pain, acute
- Central Nervous System / Pain / Pain, back upper/lower
- Central Nervous System / Pain / Pain, inflammatory
- Musculoskeletal / Skeletal / Rheumatic disorders (other)
- Musculoskeletal / Skeletal / Rheumatoid arthritis
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us